RUTW241219C2040000
- 0.00
- 0.000.00%
Russell 2000 Index Newsroom
Wall Street is not afraid of the Federal Reserve's "hawkish interest rate cuts"; will the "Christmas rally" in the U.S. stock market arrive as scheduled?
Wall Street analysts are not overly concerned and believe that Wednesday's sell-off presents a good buying opportunity, and a strong reaction to the Federal Reserve meeting is unlikely to disrupt this year's 'Santa Claus rally' momentum.
IonQ Shares Are Trading Higher After Craig-Hallum Raised Its Price Target on the Stock From $22 to $45 While Maintaining a Buy Rating.
4 Dividend Picks For 2025: JPMorgan's Top Income Stocks To Energize Your Portfolio
Arrowhead Pharma Analyst Ratings
No Pain, No Gain: Nike's Turnaround Plan Will Test Investors' Pain Threshold
Bitcoin Dives Under $100K as Trump-fueled Surge Reverses After Fed
Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday
Nu Skin Enterprises Analyst Ratings
Joby Aviation Enters Final FAA Certification Phase, Shares Take Off
Compass Point Downgrades Innovative Ind Props to Neutral, Lowers Price Target to $78
RxSight Cut to Hold at Stifel on Competition Concerns
Craig-Hallum Initiates Coverage On Rigetti Computing With Buy Rating, Announces Price Target of $12
Rigetti Computing Analyst Ratings
Tompkins Finl Analyst Ratings
Financial Institutions Analyst Ratings
Craig-Hallum Maintains Buy on IonQ, Raises Price Target to $45
Arrow Finl Analyst Ratings
IonQ Analyst Ratings
Goldman Sachs Maintains Neutral on Chart Industries, Raises Price Target to $201
Spotlight on Humacyte: Analyzing the Surge in Options Activity